US2023200691A1PendingUtilityA1

Analyte sensor

Assignee: DEXCOM INCPriority: Feb 22, 2006Filed: Feb 21, 2023Published: Jun 29, 2023
Est. expiryFeb 22, 2026(expired)· nominal 20-yr term from priority
A61B 5/15142A61B 5/14532A61B 5/742A61B 5/002A61B 5/1411A61B 5/1473A61B 5/72A61B 5/746A61B 5/14865A61B 5/0004A61B 5/1495
83
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure relates generally to systems and methods for measuring an analyte in a host. More particularly, the present disclosure relates to systems and methods for transcutaneous measurement of glucose in a host.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A system for measuring an analyte concentration in a host, the system comprising:
 a transcutaneous analyte sensor; and   sensor electronics configured to operatively connect the transcutaneous analyte sensor.   
     
     
         2 . A method for processing data from a transcutaneous analyte sensor, the method comprising:
 receiving sensor data indicative of an analyte concentration in the host; and   processing, using a processor, the sensor data.

Join the waitlist — get patent alerts

Track US2023200691A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.